Application of high‐throughput mini‐bioreactor system for systematic scale‐down modeling, process characterization, and control strategy development
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
High‐throughput systems and processes have typically been targeted for process development and optimization in the bioprocessing industry. For process characterization, bench scale bioreactors have been the system of choice. Due to the need for performing different process conditions for multiple process parameters, the process characterization studies typically span several months and are considered time and resource intensive. In this study, we have shown the application of a high‐throughput mini‐bioreactor system viz. the Advanced Microscale Bioreactor (ambr15 TM ), to perform process characterization in less than a month and develop an input control strategy. As a pre‐requisite to process characterization, a scale‐down model was first developed in the ambr system (15 mL) using statistical multivariate analysis techniques that showed comparability with both manufacturing scale (15,000 L) and bench scale (5 L). Volumetric sparge rates were matched between ambr and manufacturing scale, and the ambr process matched the pCO 2 profiles as well as several other process and product quality parameters. The scale‐down model was used to perform the process characterization DoE study and product quality results were generated. Upon comparison with DoE data from the bench scale bioreactors, similar effects of process parameters on process yield and product quality were identified between the two systems. We used the ambr data for setting action limits for the critical controlled parameters (CCPs), which were comparable to those from bench scale bioreactor data. In other words, the current work shows that the ambr15 TM system is capable of replacing the bench scale bioreactor system for routine process development and process characterization. © 2015 American Institute of Chemical Engineers Biotechnol. Prog. , 31:1623–1632, 2015
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Addition of Valproic Acid to CHO Cell Fed-Batch Cultures Improves Monoclonal Antibody Titers
Yang, W. C., Lu, J., Nguyen, N. B., Zhang, A., Healy, N. V., Kshirsagar, R., Ryll, T., & Huang, Y.-M. (2014) · Molecular Biotechnology · doi:10.1007/s12033-013-9725-x · Cited by 89 · cited 1×
“Typical mammalian cell culture processes operated in fedbatch mode take two to three weeks.(1,5) In order to increase The first two authors are co-first authors.”
BackgroundSelf-citationTescione, L., Lambropoulos, J., Paranandi, M. R., Makagiansar, H., & Ryll, T. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25330 · Cited by 46 · cited 4×
“The prerequisite for any process characterization study is the successful development and qualification of an appropriate scale-down model.(4,19,21,22) We have shown using statistical multivariate techniques that the scale-down model developed in the ambr system is comparable to manufacturing scale as well as bench sc…”
BackgroundMethodInfluentialSelf-citation
Cited by
High-Throughput Screening Technology in Industrial Biotechnology
Zeng, W., Guo, L., Xu, S., Chen, J., & Zhou, J. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2020.01.001 · Cited by 317
Xu, P., Clark, C., Ryder, T., Sparks, C., Zhou, J., Wang, M., Russell, R., & Scott, C. (2017) · Biotechnology Progress · doi:10.1002/btpr.2417 · Cited by 83
Scale‐Down Model Development in ambr systems: An Industrial Perspective
Sandner, V., Pybus, L. P., McCreath, G., & Glassey, J. (2019) · Biotechnology Journal · doi:10.1002/biot.201700766 · Cited by 63
Toward Biotherapeutic Product Real‐Time Quality Monitoring
Guerra, A., von Stosch, M., & Glassey, J. (2019) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2018.1524362 · Cited by 58
Manahan, M., Nelson, M., Cacciatore, J. J., Weng, J., Xu, S., & Pollard, J. (2019) · Biotechnology Progress · doi:10.1002/btpr.2870 · Cited by 50
Rowland‐Jones, R. C., van den Berg, F., Racher, A. J., Martin, E. B., & Jaques, C. (2017) · Biotechnology Progress · doi:10.1002/btpr.2459 · Cited by 48
Metadata
- Authors
- Janakiraman, V., Kwiatkowski, C., Kshirsagar, R., Ryll, T., & Huang, Y.
- Venue
- Biotechnology Progress
- Publisher
- Wiley
- Published
- 2015-09-28
- Volume
- 31
- Issue
- 6
- Pages
- 1623-1632
- ISSN
- 1520-6033 (ISSN-L)
- 8756-7938
- OpenAlex
- W1942150801
- Cited by
- 72
- References
- 2
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.